Several different PON-1 polymorphisms have been identified in the Japanese population and have been linked to a differential risk for atherogenic dyslipidemia, diabetes, diabetic microvascular complications, stroke, and osteoporosis [63,64,65,66,67,68,69]. Here, PON1 is linked to osteoporosis.